文献
J-GLOBAL ID:201702258172038226
整理番号:17A1830718
癌治療のためのAtuveciclib(BAY 1143572),最初の高度に選択的な,臨床PTEFb/CDK9阻害剤の同定【Powered by NICT】
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer
著者 (27件):
Luecking Ulrich
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Scholz Arne
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Lienau Philip
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Siemeister Gerhard
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Kosemund Dirk
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Bohlmann Rolf
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Briem Hans
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Terebesi Ildiko
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Meyer Kirstin
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Prelle Katja
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Denner Karsten
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Bomer Ulf
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Schaefer Martina
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Eis Knut
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Valencia Ray
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Ince Stuart
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
von Nussbaum Franz
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Mumberg Dominik
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Ziegelbauer Karl
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
,
Klebl Bert
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Choidas Axel
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Nussbaumer Peter
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Baumann Matthias
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Schultz-Fademrecht Carsten
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Ruehter Gerd
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Eickhoff Jan
(Lead Discovery Center GmbH (LDC), Otto-Hahn-Str. 15, 44227, Dortmund, Germany)
,
Brands Michael
(Bayer AG, Pharmaceuticals Division, Drug Discovery, Muellerstr. 178, 13353, Berlin, Germany)
資料名:
ChemMedChem
(ChemMedChem)
巻:
12
号:
21
ページ:
1776-1793
発行年:
2017年
JST資料番号:
W1573A
ISSN:
1860-7179
CODEN:
CHEMGX
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)